Income from operations fell to Rs 2,189 cr in Q4FY22 from Rs 2,372 cr in Q4FY21. Amount set aside for impairment on financial instruments declined to Rs 92 cr from Rs 316 cr
'We believe that the lodgment of the complaint against the petitioners and continuity of the proceedings, is an abuse of process of law', the high court said in its judgement
Funds can be raised via NCDs on one or more tranches as private placement
Regulator says it has not found any wrongdoing on company's part with respect to the specific allegations made against it in various PILs and complaints
Panacea Biotec may see some action on plans to launch a comprehensive coronavirus vaccine in association with THSTI.
Sequentially, however, consolidated net profit rose by 5.94% from Rs 286 crore in Q2FY22
The stock was down almost 23 per cent from Thursday intraday high; while the stock took place at an average price of Rs 264 per share
A combined 47.34 million equity shares, representing 10.23 per cent total equity of Indiabulls Housing Finance changed hands on the NSE and BSE as of 09:27 AM